Jagsonpal Pharmaceuticals Limited specializes in the development and production of bulk drugs and pharmaceutical formulations. Their focus areas include women's health, pain and analgesics, and general medicine. The company offers a wide range of general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products. They also provide women's healthcare products, including pregnancy care and products for managing dysfunctional uterine bleeding complications. Additionally, Jagsonpal Pharmaceuticals Limited offers pain management and bone and joint care products. Their drugs are available in various forms, including tablets, capsules, and syrups. Founded in 1964 and headquartered in New Delhi, India, Jagsonpal Pharmaceuticals Limited operates as a subsidiary of Aresko Progressive Private Limited.
Navigation section
Jagsonpal Pharmaceuticals Limited
- 681.05 -4.85(-0.71%) 688.30 -0.45(-0.07%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 671.85 671.95 | 692.45 691.60 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 273.60 (27-Mar-2024) 270.05 (14-Mar-2024) | 820.10 (29-Nov-2024) 820.05 (29-Nov-2024) |
- Open
- 678.70 680.00
- Previous Close
- 685.90 688.75
- Volume
- 0.70
- Total Traded value
- 4.76 (₹ Lakhs)
- Upper circuit
- 823.05 470.25
- Lower circuit
- 548.75 313.55
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 899 | 4 |
| Bid Price | Quantity |
|---|---|
| 682.30 | 899.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 899 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 4,418 |
Fundamentals
| Market Cap: | ₹18.06 Cr |
| PE Ratio (TTM): | 75.07 |
| PB Ratio: | 9.25 |
| Industry P/E: | 67.73 |
| Debt to Equity: | 0.00 |
| ROE: | 12.33 |
| EPS (TTM): | 9.18 |
| Book Value: | 61.21 |
| Face Value: | 5.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 57.83 Cr | 60.15 Cr | 55.45 Cr | 60.14 Cr | 60.53 Cr |
| Profit | 7.47 Cr | 7.48 Cr | 5.60 Cr | 7.78 Cr | 10.41 Cr |
| Expense | 50.14 Cr | 52.06 Cr | 50.69 Cr | 52.01 Cr | 47.85 Cr |
| Comprehensive income | 7.77 Cr | 7.46 Cr | 5.54 Cr | 7.79 Cr | 1.12 Cr |
| EPS | 2.84 | 2.85 | 2.14 | 2.97 | 3.97 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Jagsonpal Pharmaceuticals Limited | Mar, 2000 May, 1987 | Pharmaceuticals Pharmaceuticals | JAGSNPHARM JAGSNPHARM |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Jagsonpal Pharmaceuticals Limited FAQ's
What is the range of today's stock performance for Jagsonpal Pharmaceuticals Limited?
Today's stock performance witnessed a fluctuation from a minimum of 671.85 on the NSE (National Stock Exchange) to a maximum of 692.45. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 671.95 to a high of 691.60.
What are the 52-week low and high values for Jagsonpal Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 273.60 (occurred on 27-Mar-2024) and a high of 820.10 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 270.05 (on 14-Mar-2024), and the 52-week high is 820.05 (on 29-Nov-2024).
What was the opening and previous closing prices for Jagsonpal Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 273.60 (occurred on 27-Mar-2024) and a high of 820.10 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 270.05 (on 14-Mar-2024), and the 52-week high is 820.05 (on 29-Nov-2024).
What is the total volume and traded value for Jagsonpal Pharmaceuticals Limited for the day?
The total volume is 1, and the total traded value is 4.76 (₹ Lakhs).
What are the upper and lower circuit limits for Jagsonpal Pharmaceuticals Limited?
The upper circuit limit is 823.05, and the lower circuit limit is 548.75.
What is the market cap and PE ratio for Jagsonpal Pharmaceuticals Limited?
The market cap is ₹18.06 Cr, and the PE ratio (TTM) is 74.84.
What is the PB ratio, industry P/E, and debt to equity ratio for Jagsonpal Pharmaceuticals Limited?
The PB ratio is 11.13, industry P/E is 67.73 , and the debt to equity ratio is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Jagsonpal Pharmaceuticals Limited?
ROE is 12.33, EPS is 9.18, book value is 61.21
What are the revenue and profit figures for the latest quarter and previous quarters for Jagsonpal Pharmaceuticals Limited?
In Sep 2023, Revenue is ₹578290000.00, and Profit is ₹74720000.00. In Jun 2023, Revenue is ₹601530000.00, and Profit is ₹74790000.00.
When was Jagsonpal Pharmaceuticals Limited listed, and what industry does it belong to?
The company, Jagsonpal Pharmaceuticals Limited, was listed in Mar 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is JAGSNPHARM.
What is the current shareholding pattern of the Jagsonpal Pharmaceuticals Limited?
As of latest available update, promoters hold 68.71%, the public holds 31.29%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 94
